CURRICULUM VITAE
STEVEN MICHAEL ANDERSON, PhD
PLACE AND DATE OF BIRTH:
Fergus Falls, Minnesota, July 7, 1954
EDUCATION:
Fergus Falls Community College
St. Cloud State University
Iowa State University
A.A. 1974
B.A. 1976
Ph.D. 1981
EXPERIENCE:
Graduate Research Assistant, Iowa State University
1977-81
Postdoctoral Fellow, Waksman Institute of Microbiology,
Rutgers University
1981-84
Assistant Professor, Department of Biology, University
of North Carolina at Greensboro
1984-89
Adjunct Assistant Professor, Department of Biology,
University of North Carolina at Greensboro
1990-98
Associate Director, Department of Molecular Pathology,
Roche Biomedical Laboratories, Inc.
1990-92
Director, Department of Molecular Pathology/Immunohistochemistry
Roche Biomedical Laboratories, Inc.
1993-94
Technical Director, Oncology, Roche Biomedical Laboratories, Inc.
1995-96
Director, Oncology and Infectious Diseases, Laboratory
Corporation of America
1996-97
Senior Technical Director, Center for Molecular Biology and
Pathology
1997-2000
Associate Vice President, Laboratory Corporation of America
1998-2000
Vice President, Chief Scientific Officer, Molecular Diagnostics
Laboratory Corporation of America
2000-02
Chief Scientific Officer and Director of Operations, ViroMed Laboratories;
Vice PresidentChief Scientific Officer, Molecular Diagnostics
Laboratory Corporation of America
2002-06
December 2009
1
National Director of Research and Development, Senior Vice President
Laboratory Corporation of America
2006-2008
Chief Scientific Officer for Oncology and Genetics, Director of OperationsCenter for MolecularBiology and Pathology, Senior Vice President,
Laboratory Corporation ofAmerica
2008Director of Operations, Monogram Biosciences
2009-
JOB RESPONSIBILITIES FOR MOST RECENT POSITIONS
Senior Vice President, Chief Scientific Officer for Oncology and Genetics,
Director of Operations, Center for Molecular Biology and Pathology and Monogram
Biosciences.
Provide scientific leadership, including the evaluation and implementation of new diagnostic
technologies and applications for the areas of Oncology, Genetics and Molecular Infectious
Disease testing. Coordination of science and operations across all Oncology and Genetic testing
laboratories.
Responsible for all aspects of laboratory testing including evaluation of new technology,
development of new diagnostic assays, quality assurance and laboratory operations at the Center
for Molecular Biology (Research Triangle Park, NC) and Monogram Biosciencs (South San
Franciso, CA). The Center for Molecular Biology and Pathology offers cutting edge
technologies in the areas of Genetics, Infectous Disease and Oncology. Direct reports include
clinical laboratory directors, laboratory general manager, and quality assurance department.
Monogram Biosciences offers genotyping and phenotyping in Virology and molecular
diagnostics in Oncology. Direct reports include Directors of Research and Development and
Laboratory Operations.
Senior Vice President, National Director of Research and Development, Laboratory
Corporation of America
Responsible for the coordination and implementation of Research and Development activities
throughout the LabCorp system. This includes evaluation of technology opportunities and
applications, prioritization of projects, standardization of assay validation and development
studies, review of scientific data and coordination of implementation of new technologies.
Director of Operations, Chief Scientific Officer, ViroMed Laboratories
Responsible for all aspects of laboratory testing including evaluation of new technology,
development of new diagnostic assays, quality assurance and laboratory operations. Direct
reports include clinical laboratory director, laboratory general manager, and quality assurance
department.
December 2009
2
Vice President, Chief Scientific Officer for Molecular Diagnostics, Laboratory Corporation
of America (LabCorp)
Responsible for all aspects of laboratory testing in the areas of Genetics and Oncology. This
included the evaluation of new technology, development of new diagnostic assays, principle
investigator for specific clinical trials, quality assurance and laboratory operations. Direct reports
included loaboratory directors for Cytogenetics, Molecular Genetics, and Oncology. Served as
Discipline Director for LabCorp in the areas of Molecular Genetics and Oncology.
MEMBERSHIP IN PROFESSIONAL SOCIETIES:
American Association for the Advancement of Science
American Association of Clinical Chemistry
American Association of Tissue Banks
American Society for Human Genetics
Association for Molecular Pathology
American Society for Microbiology
Sigma Xi
OTHER PROFESSIONAL ACTIVITIES:
Instructor, "DNA Literacy for College Educators Workshop", sponsored by Carolina Biological
Supply Co., July 1989.
Instructor, "Biotechnology for High School Teachers Workshop", sponsored by the North
Carolina Biotechnology Center Secondary Education Program, August 1988 and June
1989. Book Reviewer, Harper and Row, Inc.
Contributor, Ohio Academy of Science Biotechnology Laboratory Workbook.
Contributor, Childrens Science Magazine "Monkeyshines on Health and Science".
Planning Committee, Greensboro Area Math and Science Education Center, 1984-1989.
Research Coordinating Committee, North Carolina Zoological Park, 1987-1989.
Faculty Advisor, Beta Beta Beta Biology Honor Society, 1986-1988.
Education Enhancement Grants Advisory Board, North Carolina Biotechnology Center, 19912002
Biotechnology Advisory Committee, Alamance Community College, 1992-2002
Radiation Safety Officer, Center for Molecular Biology and Pathology, Roche Biomedical
Laboratories, 1992 - 1996
Continuing Education Director, Center for Molecular Biology and Pathology, Roche Biomedical
Laboratories, 1994 - 1996
Quality Process Management Steering Committee, Center for Molecular Biology and Pathology,
Roche Biomedical Laboratories, 1995
Clinical Laboratory Information Council, 1995-1996
Center for Disease Control/DynCorp Panel on Quality Assurance Programs for Molecular
Genetics Testing 1998-1999
Technical Working Group for Nucleic Acid Standards (TWGNAS), National Institute of
Standards and Technology 1999-2000
Her-2/neu Laboratory Testing Advisory Group, Genentech 1999-2003
Coordinator, LabCorp/UNC Clinical Laboratory Sciences, Molecular Biology Program 19992002
December 2009
3
Her-2/neu Immunohistochemistry DAKO Workshop Moderator 2000-01
CAP Inspection Team Leader, 2000Oncology Advisory Group, Bayer Diagnostics, 2000-01
University of North Carolina at Greensboro Scientific Advisory Board 2002
LabCorp Continuing Medical Education Advisory Board 2003Herceptin Diagnostics Advisory Board 2004EDRN Working Group 2008NIH Biomarker Consortium-Circulating Tumor Cells Advisory Group 2008-
PUBLICATIONS:
Anderson, S., M. Santos and J. McDonald. 1980. Comparative study of the thermostability of
crude and purified preparations of alcohol dehydrogenase (E.C.1.1.1.1.) from
D.melanogaster. Drosophila Information Services 44: 13-14.
McDonald, J.F., S.M. Anderson and M. Santos. 1980. Biochemical differences between the
products of the Adh-locus in Drosophila. Genetics 95: 1013-1022.
Anderson, S. and J. McDonald. 1980. Relative in vivo stabilities of products of the Adh locus in
Drosophila. Genetics 94: 52.
Anderson, S.M. and J.F. McDonald. 1981. A method of determining the in vivo stability of
Drosophila alcohol dehydrogenase. Biochemical Genetics 19: 411-419.
Anderson, S.M. and J.F. McDonald. 1981. Changes in levels of alcohol dehydrogenase during
the development of Drosophila melanogaster. Canadian Journal of Genetics and
Cytology 23: 305-313.
Anderson, S.M., M. Santos and J.F. McDonald. 1981. Selection at the Adh-locus: Adult
survivorship in response to ethanol. Experientia 37: 463-464.
McDonald, J. and S. Anderson. 1981. Letter to the Editor - A Reply. Genetics 98: 673-675.
Anderson, S. and J. McDonald. 1983. Biochemical and molecular analysis of naturally
occurring Adh variants in Drosophila melanogaster. Proc. Nat. Acad. of Sci. 80: 47984802.
Place, A.R., S.M. Anderson and W. Sofer. 1986. Introns and domains in dehydrogenase genes.
in: "Multidomain Proteins - Structure and Evolution". Elsevier Science Publishers. pp.
175-194.
Smith, L. and S. Anderson. 1987. Thermostability of Drosophila alcohol dehydrogenase before
and after exposure to 2-propanol. Drosophila Information Services 66: 132-134.
Anderson, S. 1987. Biotechnology: The renewable frontier. (Book Review). Bios: Quarterly
Journal of Biology 58: 82-83.
December 2009
4
Barnett, S. and S. Anderson. 1988. The biochemical basis of alcohol adaptation in Drosophila.
Genome 33:30.
Anderson, S., M. Brown and J. McDonald. 1989. Post-transcriptional regulation of Drosophila
alcohol dehydrogenase. Genetics 122: S42.
Forng, E., S. Anderson and R. Cannon. 1989. A synthetic medium for Acetobacter xylinum that
can be used for isolation of auxotrophic mutants and the study of cellulose biosynthesis.
Journal of Applied and Environmental Microbiology 55:1317-1319.
Anderson, S. and S. Barnett. 1991. The involvement of alcohol dehydrogenase and aldehyde
dehydrogenase in alcohol and aldehyde metabolism in Drosophila. Genetica 83:99-106.
Chimera, J.A., S. Anderson, H. Noell and V. Rizk. 1991. Comparison of nucleic acid
hybridization with cytologic examination for detection of human papillomavirus
infection: An evaluation of ViraPap and ViraType. Clinical Chemistry 37:260-262.
Cannon, R. and S. Anderson. 1991. Biogenesis of bacterial cellulose. Critical Reviews in
Microbiology 17:435-447.
Anderson, S., M. Brown and J. McDonald. 1991. Tissue specific expression of the Drosophila
Adh gene: A comparison of in situ hybridization and immunocytochemistry. Genetica
84: 95-100.
Body, B.A., S.M. Anderson and T.H. Callaway. 1991. Laboratory testing for sexually
transmitted diseases. RBL Monograph on Infectious Disease.
Hall, P., S. Anderson and R. Cannon. 1992. Transformation of Acetobacter xylinum with
plasmid DNA by electroporation. Plasmid 28:194-200.
Ibrahim, G.K., P.E. Gravitt, K.L. Dittrich, S.N. Ibrahim, O. Melhus, J.A. Chimera, S.M.
Anderson and C.N. Robertson. 1992. Detection of human papillomavirus DNA in the
prostate by polymerase chain reaction and in situ hybridization. The Journal of Urology
148:1822-1826.
Troncone, G., S.M. Anderson, C.S. Herrington, M. de Angelis, H. Noell, J.A. Chimera and J.
O'D McGee. 1992. Comparative analysis of human papillomavirus detection by dot-blot
hybridization and non-isotopic in situ hybridization. Journal of Clinical Pathology
45:866 - 870.
Herrington, C.S., S.M. Anderson, G. Troncone, M.L. deAngelis, H. Noell, J. Chimera and J. O'D
McGee. 1993. Comparative analysis of human papillomavirus (HPV) detection by PCR
and nonisotopic in situ hybridization. J. of Pathology 169:138A.
Anderson, S. and T.H. Callaway. 1993. New technologies for the diagnosis of HPV infection.
Primary Care and Cancer 13:9-14.
December 2009
5
Herrington, C.S., S.M. Anderson, A.K. Graham and J. O'D McGee. 1993. Discrimination of
high risk HPV types by in situ hybridization and the polymerase chain reaction.
Histochemical Journal 25:191-198.
Anderson, S.M., P.K. Brooke, S.L. Van Eyck, H. Noell and W.J. Frable. 1993. Distribution of
human papillomavirus type in genital lesion from two temporarily distinct populations
determined by in situ hybridization. Human Pathology 24:547-553.
Waggoner, S.E., S.M. Anderson, J. Fuller, S. VanEyck, M.C. Luce and A.L. Herbst. 1994.
Human papillomavirus detection and p53 expression in clear cell adenocarcinomas of the
vagina and cervix. Amer. Jour. Obstet. and Gynecol. 84:404-408.
Herrington, C.S., S.M. Anderson, G. Troncone, M.L. deAngelis, S.L. VanEyck, H. Noell, J.A.
Chimera and J.O'D. McGee. 1995. Comparative analysis of human papillomavirus
detection by polymerase chain reaction and nonisotopic in situ hybridization. Journal of
Clinical Pathology. 48:415-419.
Anderson S., Ayscue, A., Baker, K., Chatterjee, A. and Lai-Goldman, M. 1995. Detection of
human papillomavirus in anogenital biopsies by an automated in situ hybridization assay.
American Jounal of Clinical Pathology 104: 337.
Day, J.D., DiGiuseppe, J.A., Yeo, C., Lai-Goldman, M., Anderson, S.M., Goodman, S.N., Kern,
S.E. and R.H. Hruban. 1996. Immunhistochemical evaluation of HER-2/neu expression
in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms.
Human
Pathology 27: 119-124.
Waggoner, S.E., S.M. Anderson, M.C. Luce, H. Tahahaski, and J. Boyd. 1996. P53 protein
expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix.
Gynecologic Oncology 60: 389-394.
Wheeler, C.M., C.A. Parmenter, C.E. Greer, S.M. Anderson, C. Stidley, S. Hunble and M.M.
Manos. 1997. Repeated measures of HPV and factors affecting DNA detection.
Obstetrics and Gynecology 88: 261-268.
Olshan, A.F., M.C. Weissler, H. Pei, K. Conay and S.M. Anderson. 1997. Alterations of the p16
gene head and neck cancer: Frequency and association with P53, PRAD-1 and HPV.
Oncogene 14:811-818.
Alcorn, T.M. and Anderson, S.M. 1998. Applications of Molecular Virology for Prognostic
testing in HIV Infection. Advance/Laboratory Medicine 3:46-52.
Dula,W. and Anderson, S.M. 1998 Diagnosis and Management of Hepatitis C infection.
Advance/Laboratory Medicine 3:65-72.
Waggoner S.E., Baurouch, D.A., Anderson, S.M, Leigh, F., and V.G. Zagaja. 1998. Bcl-2
protein expression is associated with resistance to apoptosis in clear cell adenocarcinomas
of the vagina and cervix expressing wild type p53. Annals of Surgical Oncology 5:544547.
December 2009
6
Anderson S. and Everett T. 1999. HER-2/neu Oncoprotein: A New Target in the Treatment of
Breast Cancer. Advance/Laboratory Medicine 8:36-41.
McDowell G., Brown T., Papenhausen P., and Anderson S. 2000. Enhanced second trimester
maternal serum screening for Down syndrome: Addition of Dimeric Inhibin A.
Advance/Laboratory Medicine 9: 2-8, 2000.
Liaw K., Hildesheim A., Burk R., Gravitt P., Wacholder S., Manos M., Scott D., Sherman M.,
Kurman R., Glass A., Anderson S., and Schiffman M. 2001. A prospective study of HPV
16 DNA detection by PCR and its association with acquistion and persistence of other
HPV types. Journal of Infectious Disease 183:8-15.
Anderson S. and McCune B. 2001. Immunohistochemical Testing for the Determination of
HER-2/neu Overexpression. DAKO Connection 3:6-8.
Harris L., Liotcheva V., Broadwater G., Rameriz M., Anderson S., Everett T., Harpole D., Moore
M., Berry D., Vrendenburgh J. and Bentley R. 2001. Comparison of methods and
outcome of HER-2 positivity after high-dose chemotherapy in metastatic breast cancer
patients. Journal of Clinical Oncology 19:1698-1706.
Anderson S. 2001. Human Papillomavirus and Cervical Cancer. Advance/Laboratory Medicine
10: 90-96.
Paik S., Bryant J., Tan-Chiu E., Romond E., Park K., Brown A., Yothers G., Anderson S., Smith
R., Wickerman, D., and N. Wolmark. 2002. Real world performance of HER2 testingNational Surgical Adjuvant Breast and Bowel Program experience. Journal of the
National Cancer Institute 94: 852-855.
Anderson S. 2002
Human Papillomavirus Infections and Cervical Cancer.
Microbiology Newsletter 24:113-118.
Clinical
Sardosy M.F., Schellhammer P, Bokinsky G., Kahn P, Chao P, Yore L, Zadra J, Osher G, Bridge
J, Anderson S, Johannson S, Lieber M, Soloway M and K Flomm. 2002. Clinical
evaluation of a multi-target fluorescent in-situ hybridzation assay for detection of bladder
cancer. J of Urology 168:1950-1954.
Bankowski M. and S. Anderson 2003. West Nile Virus Infection: A Review for Clinicians.
Advance/Laboratory Medicine 12: 76-82.
Alcorn T. and S. Anderson 2004. Automated DNA Sequencing. Molecular Microbiology:
Diagnostic Principles and Practices (ASM Press, ed. Pershing DH, Tenover FC,
Versalovic, J, Tang YW, Unger ER, Relman DA and TJ White) pp 153-160.
Bankowski M. and S. Anderson 2004. Clinical Applications of Real-Time PCR Technology.
Clinical Microbiology Newsletter 26:9-15.
December 2009
7
Blackwell KL, Dewhirst MW, Liotcheva V, Snyder S, Broadwater G, Lai A, Riggins G,
Anderson S, Vredenburgh J, Proia A, and LN Harris. 2004. HER-2 Gene Amplification
Correlates with Higher Levels of Angiogenesis and Lower Levels of Hypoxia in Primary
Breast Tumors. Clinical Cancer Research 10: 4083-4088.
Anderson S. 2005. Human Papillomavirus
Advance/Laboratory Medicine. 14: 92-99.
and
Cervical
Cancer:
An
Update.
Mass RD, Press MF, Anderson SM, Cobleigh MA, Vogel CL, Dybdahl N, Lebierman, G. and D.
Slamon. 2005. Evaluation of Clinical Outcomes According to HER2 Detection by
Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated
with Trastuzumab. Clinical Breast Cancer Research 6: 240-246.
Dybdahl N., Lieberman G., Anderson S., McCune, B, Bajamonde A., Cohen R., Mass R.,
Sanders C. and M. Press. 2005. Determination of HER2 Gene Amplification by
Fluorescence In Situ Hybridization and Concordance with the Clinical Trials
Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for
Treatment with Trastuzumab. Breast Cancer Research and Treatment 93:3-11.
Reddy J.C., Barker C.M., Anderson S.M., and P.M. Klein. 2006. Concordance Between Central
and Local Laboratory Testing from a Community-Based Clinical Trial. Breast Cancer
Research 7:153-157.
Anderson S. 2008. Considerations for HCV and HIV Viral Load Testing. Advance/Laboratory
Medicine 17s:17.
Tutt A., Wang A., Lau K., Gillett C,. Chew K., Rowland C., Dai H., Kwok S., Ryder K., Shu H.,
Springall R., McCallie B., Kam-Morgan L., Anderson S., Buerger H., Gray J.,
Bennington J., Esserman L., Hastie T., Broder S., Sninsky J., Brandt B., and F. Waldman.
2008. Risk Estimation of Distant Metastasis in Node-Negative, Estrogen ReceptorPositive Breast Cancer Patients Using an RT-PCR Based Prognostic Expression
Signature. BMC Cancer 8:339-377.
Iverson AA, Gillett C, Cane P, Santini CD, Vess TM, Kam-Morgan L, Wang A, Eisenberg M,
Rowland CM, Hessling JJ, Border S, Sninsky JJ, Tutt, A, Anderson S, Chang SYP 2009.
A Single-Tube Quantitative Assay for mRNA levels of Hormonal and Growth Factor
Receptors in Breast Cancer Specimens. Journal of Molecular Diagnostics 11: 117-130.
Anderson S., 2009. Applications of Microarray Technologies in Anatomic Pathology. Dako
Connection 13: 76-79.
EDUCATIONAL MATERIALS:
Anderson, S.M. 1989. Genetic Engineering. Monkeyshines on Science and Health. 3:10-12.
Body, B.A., S.M. Anderson and T.H. Callaway 1991. Laboratory testing for sexually transmitted
diseases. RBL Monograph on Infectious Disease.
December 2009
8
Cannon, R.E. and S.M. Anderson 1993. Cellulose production by Acetobacter xylinum. The
Ohio Science Workbook: Biotechnology pp. 31-33.
Anderson, S.M., and R.E. Cannon 1993. Plasmid DNA isolation and characterization. The Ohio
Science Workbook: Biotechnology pp. 101-103.
Lai-Goldman, M., L.E. Osborne, J. Fuller and S.M. Anderson 1994. New technologies for
diagnosis and disease monitoring in patients with chronic myelogenous leukemia. ASCP
Check Sample 18:51-65.
ABSTRACTS (since 1987):
Forng, E.R., S.M. Anderson and R.E. Cannon. 1987. Development of a synthetic medium for
Acetobacter xylinum. Annual Meeting of the American Society for Microbiology.
Anderson, S., G. Keesler, J. Warren and R. Cannon. 1988. RP4 conjugation between E. coli and
A. xylinum. Annual Meeting of the American Society for Microbiology.
Fry, D., F. Keegan and S. Anderson. 1988. ADH and ALDOX activity in Drosophila embryos.
National Congress on Undergraduate Research.
Barnett, S. and S. Anderson. 1988. The biochemical basis of alcohol adaptation in Drosophila.
XVIth International Congress of Genetics.
Anderson, S., M. Brown and J. McDonald. 1989. Post-transcriptional regulation of Drosophila
alcohol dehydrogenase. Annual Meeting of Genetics Society of America.
Smith, R., R. Cannon and S. Anderson. 1990. Characterization of a plasmid from Acetobacter
xylinum ATCC 27369: Wild type and cellulose-negative mutants. Annual Meeting of
the American Society for Microbiology.
Chimera, J., Anderson, S., Noell, H. and V. Rizk. 1990. Comparison of nucleic acid
hybridization and cytologic examination for the detection of human papillomavirus
infection: An evaluation of ViraPap and ViraType. Fourth International Conference on
Human Papillomaviruses and Genital Carcinoma.
Hall, P., S. Anderson and R. Cannon. 1991. Transformation of Acetobacter xylinum with
plasmid DNA by electroporation. Annual Meeting of the American Society for
Microbiology.
Gravitt, P., H. Noell, P. Brooke, J. Chimera, W.J. Frable and S. Anderson, 1991. A comparison
of in situ hybridization and polymerase chain reaction for the detection of human
papillomavirus in paraffin-embedded tissue. ASM Conference on Biotechnology.
December 2009
9
Parmenter, C.A., H.M. Bauer, T.M. Becker, J. Miller, S. Anderson, M.M. Manos and C.M.
Wheeler. 1991. Determinants of genital human papillomavirus infection in a female
university population: The New Mexico Experience. International Papillomavirus
Conference.
Gravitt, P., G. Ibrahim, C. Robertson, S. Ibrahim, O. Melhus, J. Chimera and S. Anderson.1991.
Detection of human papillomavirus DNA in prostate by polymerase chain reaction and in
situ hybridization. International Papillomavirus Conference.
Gravitt, P., H. Noell, P. Brooke, C. Ellington, J. Chimera, W. Frable and S. Anderson. 1991. A
comparison of in situ hybridization and polymerase chain reaction for the detection of
human papillomavirus DNA in paraffin-embedded tissue. International Papillomavirus
Conference.
Wheeler, C.M., C.A. Parmenter, C.E. Greer, S. Anderson, C. Stidley, S. Humble and M.M.
Manos. 1991. Repeated measures of HPV and factors affecting DNA detection.
International Papillomavirus Conference.
Ibrahim, G., P. Gravitt, S. Anderson, S. Ibrahim, O. Melhus, J. Chimera and C. Robertson. 1991.
Detection of human papillomavirus DNA in prostate by polymerase chain reaction and in
situ hybridization. International Society of Urology.
Anderson, S. 1992. The polymerase chain reaction overview and clinical applications.
American Association for Clinical Chemistry.
Anderson, S.M., P.K. Brooke, S.L. Van Eyck, H. Noell and W.J. Frable. 1992. Distribution of
human papillomavirus type in archival tissue from 1964-65 and 1988-89. International
Papillomavirus Conference.
Somers, K.D., G.L. Schechter, M.A. Merrick, G. Carey, M.E. Lopez, S. Anderson, S. Van Eyck,
J.S. Hill and T.C. Carey. 1992. p53 mutations in HPV DNA positive cell lines derived
from squamous cell carcinoma of the head and neck. International Papillomavirus
Conference.
Anderson, S.M., P.K. Brooke, S. Van Eyck, H. Noell and W.J. Frable. 1992. Distribution of
human papillomavirus types in archival tissues from 1964-65 and 1988-89. ASCP/CAP
Fall Meeting.
Herrington, C.S., S.M. Anderson, G. Troncone, M.L. de Angelis, H. Noell, J. Chimera and J.
O'D McGee. 1993. Comparitive analysis of human papillomavirus (HPV) detection by
PCR and nonisotopic in situ hybridization (NISH). Pathological Society of of Great
Britain and Ireland Annual Meeting.
Waggoner, S.E., S. Anderson, S. VanEyck, M. Luce and A. Herbst. 1993. Human
papillomavirus detection and p53 expression in clear cell adenocarcinomas of the vagina
and cervix. The American College of Obstetricians and Gynecologists Annual Meeting.
December 2009
10
Anderson, S.M., J. Fuller, Y. Liu, H. Noell, K. Ellington and M. Lai-Goldman. 1993. Cellular
proliferation in breast carcinomas as determined by MIB-1 immunostaining. ASCP/CAP
Fall Meeting.
Anderson, S.M., S. Waggoner, S. VanEyck, J. Fuller and M. Luce. 1993. Human
papillomavirus detection and p53 expression in clear cell adenocarcinomas. International
Papillomavirus Conference.
Carey, T.E., S.E. Grenman, R. Grenman, M.J. Worsham, D.L. VanDyck, D.J.S. Hayashida, K.D.
McClatchey, C.R. Bradford, J.A. Roberts, K.D. Somers and S.M. Anderson. 1993. UMGCC01, a new HPV-16 positive cell line from a cervical glassy cell carcinoma.
International Papillomavirus Conference.
Waggoner S., Xu, K. Micetech, Anderson S., DeGeest K., and M. Turyk. 1993. Interleukin-6
production by normal, dysplastic, malignant and HPV 16 tranformed human cervical
cells. International Papillomavirus Conference.
Anderson S.M., J.L. Becker and P.R. Papenhausen. 1994. Verification of an i(5p) marker
chromosome in a mixed Mullerian tumor of the ovary by fluorescence in situ
hybridization. FISH: Clinical Applications in Cancer and Genetics.
Anderson S., S. Van Eyck, G. Farr and M. Johnson 1994. Detection of Cytomegalovirus in
paraffin-embedded tissue by in situ hybridization. American Public Health Association
Annual Meeting
Anderson S.M., Y. Liu and P.R. Papenhausen 1994. Identification and characterization of
marker chromosomes, de novo rearrangements and microdeletions in 100 cases with
fluorescence in situ hybridization (FISH). American Society of Human Genetics
Papenhausen P.R. and S. Anderson 1994. Diagnostic/prognostic molecular cytogenetic followup applied in satellited marker cases. American Society of Human Genetics.
Waggoner, S., S. Anderson, M. Luce, H. Tahahosi, and J. Boyd 1995. P53 expression and gene
analysis is clear all adenocarcinomas at the vagina and cervix. Twenty-sixth annual
meeting of the Society of Gynecologic Oncologists.
Anderson, S., T. Green, A. Ascyue, K. Baker and C.Cooke 1995. Detection of human
papillomavirus in a duodenal metastasis by in situ hybridization and the polymerase chain
reaction. International Papillomavirus Conference.
Olshan, A., M. Weissler, H. Pei, K. Conway and S. Anderson 1995. HPV and alterations of p53,
p16 and PRAD-1 in head and neck cancers. International Papillomavirus Conference.
Anderson, S., A. Ayscue, K. Baker, A. Chatterjee and M. Lai-Goldman 1995. Detection of
human papillomavirus in Anogenital biopsies by automated in situ hybridization.
ASCP/CAP Fall Meeting.
December 2009
11
Tepperberg, J.H., I.K. Gadi, S.M. Anderson, M.R. Rossi, A. DeJesus and P.R. Papenhausen
1995. Molecular analysis of a rare ring chromosome in a young girl with mild features of
Down syndrome. American Society of Human Genetics.
Papenhausen, P.R., M. Luce, I.R. Gadi, J.H. Tepperberg, and S.M. Anderson 1995. Molecular
analysis of SRY/ZFY in cases of phenotype/genotype sex discordance. American Society
of Human Genetics.
Harris L.N., Liotcheva V., Broadwater G., Anderson S., Vrendenbergh J., Rameriz M., MooreJoshi M., and R. Bentley 1999. Method of measuring ERB2 gives different results in
predicting response to high-dose chemotherapy (HDC) in breast cancer patients.
American Society of Clinical Oncology.
Pratt V., Brown, T., Kam-Morgan L., Eisenberg M. and Anderson S. 1999. Mutation detection
and referral testing for cystic fibrosis. Association for Molecular Pathology Annual
Meeting.
Mass R., Sanders C., Kasian C., Everett T., Johnson L. and Anderson S. 2000. The concordance
between the clinical trials assay (CTA) and fluorescence in situ hybridization (FISH) in
the Herceptin pivotal trials. American Society of Clinical Oncology.
Blackwell K., Liotcheva V., Haroon Z., Fung K., Broadwater G., Anderson S., Vredenburgh J.,
Proia A., Greenberg C., Dewhurst M., and Harris L. 2000. Her-2 Gene Amplification
Correlates with Higher Levels of Angiogenesis in Primary Breast Tumors. American
Society of Clinical Oncology.
Pratt V., Brown, T., Kam-Morgan L., Eisenberg M. and Anderson S. 2000. Mutation detection
and referral testing for cystic fibrosis. American Society of Human Genetics Annual
Meeting.
Mass R.D., Press M., Anderson S., Murphy M., and Slamon D. 2001. Improved Survival
Benefit from Herceptin (Trastuzumab) in Patients Selected by Fluorescence In Situ
Hybridization. American Society of Clinical Oncology Annual Meeting.
Levine E.A., Inman J.L., White W., Pettanati M., Anderson S., and T. Kute. 2001. Absence of
HER-2/neu Expression in Metastatic Melanoma. American Society of Clinical Oncology
Annual Meeting.
Sardosy M. , Schellhammer P., Kahn P., Zadra J., Bridge J., Johansson S., Anderson S., and K.
Flom. 2001. Clinical Evaluation of a multi-target fluorescent in situ hybridization (FISH)
assay for bladder cancer detection. American Urology Association Annual Meeting.
Mass R., Press M., Anderson S., and D. Slamon. 2001 Improved survival benefit from
Herceptin (trastuzumab) and chemotherapy in patients selected by fluorescence in situ
hybridization. 24th Annual San Antonio Breast Cancer Symposium.
December 2009
12
Press M., Slamon D, Cobleigh M, Vogel C, Zhou J-Y, Anderson S, Liberman G, and R. Mass.
2002. Improved clinical outcomes for Herceptin treated patients selected by fluorescence
in situ hybridization. USCAP Annual Meeting.
Press M, Anderson S, Dybdal N, Lieberman G, and R Mass. 2002. Fluorescence in situ
hybridization (FISH) rior to immunohistochemistry (IHC) for determining HER-2 status:
The Herceptin experience. USCAP Annual Meeting.
Eberhard D A, Huntzicker E and S. Anderson 2002. Epidermal growth factor receptor
immunohistochemistry (EGFR IHC): Assay selection and application to breast cancers.
ASCO Annual Meeting.
Klein P, and S. Anderson.
2002
FISH identifies HER-2+ patients missed with
immunohistochemistry. ASCO Annual Meeting.
Belzer S., Anderson S, and MJ Bankowski 2002. Parvovirus B-19 DNA PCR as an adjunct to
serological testing. Association for Molecular Pathology Annual Meeting.
Anderson S. and P Klein 2002. Concordance between local labs and a central lab using FISH
and IHC for HER-2 testing. San Antonio Breast Cancer Symposium.
Winer E, Cobleigh M., Dickler M, Miller K, Fehrenbacher L, Jones CM, Anderson S, Eberhard
D, and R. Justice. 2002. Phase II multicenter study to evaluate the efficacy and safety of
Tarceva (erlotinib HCL, OSI-774) in women with previously treated, locally advanced, or
metastatic breast cancer. San Antonio Breast Cancer Meeting.
Anderson S, Gilkerson E, and P Klein. 2003. Concordance between local labs and a central
reference lab using FISH and IHC for HER2 testing. Annual Meeting of the United
Stated and Canadian Academy of Pathology.
Bankowski MJ, Belzer SW, Lembke BD, and SM Anderson. 2003. Standardization of nucleic
acid amplification using the MagnaPure LC and the Light Cycler for real-time PCR
detection of polyomaviruses. Clearwater Virology Symposium.
Bankowski MJ, Belzer SW, Lembke BD and SM Anderson. 2003. . Standardization of nucleic
acid amplification using the MagnaPure LC and the Light Cycler for real-time PCR
detection of herpes viruses. Clearwater Virology Symposium.
Bankowski MJ, Belzer S, Lembke B, Hodges-Savola C., Wold K, and S Anderson. 2003.
Detection of human human IgM and IgG antibody to West Nile Virus (WNV) using
indirect immunofluorescence antibody (IFA) testing during the 2002 WNV season.
Annual Meeting for the American Society for Microbiology
Bankowski MJ, Belzer S, Lembke B and S Anderson. 2003. Real-time PCR (Light-Cycler)
detection of West Nile Virus (WNV) RNA in human serum and CSF during the 2002
WNV season. Annual Meeting for the American Society for Microbiology
December 2009
13
Anderson SM, Gocke D, Belzer SW, Gamble A, Campanella C. and MJ Bankowski. 2003.
Detection of Hepatitis C Virus RNA in cadaveric serum or plasma samples using nucleic
acid amplification. Annual Meeting of the American Association of Tissue Banks.
Romain C, Ybarra A, and S.M. Anderson 2003. Evaluation of an Oligonucleotide Ligation
Assay for Cystic Fibrosis Testing. Annual Meeting of the Association for Molecular
Pathology.
Lembke B., Belzer S, Anderson S. and MJ Bankowski 2003. Standardization of Real-time
nucleic acid amplification of Bordetella. Annual Meeting of the Association for
Molecular Pathology.
Bankowski MJ, Hodges-Savola C, Zeller J, White J, and S.M. Anderson. 2004. DirectigenTM
Flu A/B, Shell Vial, and Influenza Strain Challenge for the 2003-2004 Respiratory
Season. Clearwater Virology Symposium.
Bankowski MJ, Hodges-Savola C., Belzer S.W., Lembke B. and S.M. Anderson 2004. ELVIS,
Viral Culture, and Real-Time PCR for the Direct Detection of Herpes Simplex Virus in
Clinical Specimens. Clearwater Virology Symposium.
Bankowski MJ, Belzer S, Lembke B and SM Anderson. 2004 Prevalence of Norovirus RNA in
Stool Cases of Human Gastroenteritis Where Rotavirus and other Stool Testing is
Negative. Annual Meeting of the American Society for Microbiology
Anderson SM, Belzer S, Lembke B, and MJ Bankowski. 2004 Real-time PCR (Light Cycler)
Multiplex Detection of Polyomavirus (BK and JC) DNA in Human Blood, CSF and
Urine Specimens. Annual Meeting of the American Society for Microbiology.
Anderson S.M, Reddy J, Lieberman G, Rai S, and P. Klein. 2004. Concordance Between Central
and Local Lab IHC and FISH HER2 Testing in a Community-Based Trial of First-Line
Trastuzumab Plus a Taxane in HER2+ Metastatic Breast Cancer. American Society of
Clinical Oncology Annual Meeting.
Bankowski M.J., Belzer, S.W., Lembke B.D., Gocke D., Gamble A., and S.M. Anderson. 2004.
Preclinical Validation of the COBAS AmpliscreenTM Test for the Amplification and
Detection of HIV-1 and HCV in Tissue Donor Blood Specimens. American Association
of Tissue Banks Annual Meeting.
Anderson S.M., Reddy J., and P.M Klein. 2004 Concordance Between Central and Local
Laboratory Immunohistochemistry and Fluorescence In Situ Hybridization HER2 Testing
in a Community-Based Trial of First Line Trastuzumab plus Taxane in HER2 Positive
Metastatic Breast Cancer. Genentech BioOncology Solid Tumor Investigator Meeting.
Bankowski M, Anderson S, Belzer S. and B. Lembke. 2004. Amplification and Detection of
HIV-1 and HCV in Tissue Donor Blood using NAT PCR Testing. American Association
of Blood Banks Annual Meeting.
December 2009
14
Bankowski, M, Belzer S, Lembke B, Abelson M, and S. Anderson. 2004. Amplification and
Detection of Hepatitis C Virus (HCV) in Tissue Donor Specimens Using the COBAS
HCV Amplicor and AmpliscreenTM Tests. Association for Molecular Pathology Annual
Meeting.
Bankowski, M., Hodges-Savola C., Belzer S., Lembke B. and S. Anderson. 2005. Evaluation of
a Real-time PCR Test for the Direct Detection of Influenza Virus. Clearwater Virology
Symposium.
Bankowski M., Belzer S., Lembke B., Mix L, and S. Anderson. 2005. Direct Detection of
Human Metapneumovirus in Clinical Specimens Using Real-Time PCR. Clearwater
Virology Symposium.
Bankowski M., Belzer S., Lembke B, and S. Anderson. 2005. The Extraction of Nucleic Acids
from a Variety of Viruses and Clinical Specimens Using the MDx BioRobot and a
Modification of the Viral Kit. Clearwater Virology Symposium.
Bankowski M., Belzer S., Lembke B., Johnson S., and S. Anderson. 2005. Evaluation of the
MultiCode-RTx Using Real-Time PCR for the Detection of Enterovirus in Clinical
Specimens. Clearwater Virology Symposium.
Bankowski M., Belzer S., Lembke B., Mix L., Gumz T., and S. Anderson. 2005. Detection of
Trichomonas vaginalis in Clinical Specimens Using Real-Time PCR Compared to
Culture Isolation. Annual Meeting of the American Society of Microbiology.
Tran H. and S. Anderson. 2006 Carrier and Donor Screening for Gamete Donors: Test
Utilization in Conjunction with Recommendations and Guidance. American College of
Medical Genetics Annual Meeting
Zeimis R., Belzer S., Mix L. and S. Anderson. 2006 Evaluation of Bacterial Identification
Systems using the Vitek2 Compact and Biolog Systtems Compared to 16S Ribosomal
RNA Sequencing. American Society of Microbiology Annual Meeting/
Bankowski M., Belzert S., Lembke B., Loeffelholz M, Hayden R. and S. Anderson. 2006.
Evaluation of a Real-Time PCR Multiplex for the Direct Detection of Influemza Virus
Type A, Influenza Virus Type B and RSV in Clinical Specimens. Clearwater Virology
Symposium Annual Meeting
Bankowski M,, Belzer S,, Lembke B., Loeffelholz M, and S. Anderson 2006 Validation of a
Real-Time PCR Test for the Deteciton and Subtyping of Influenza A Virus in Clinical
Specimens. Clearwater Virology Symposium Annual Meeting.
Wang A., Chew K., Chang J, Lau K., Santini C. ,Vess T, Eisenberg M, Bennington T.,
Anderson S., Sninsky J., Waldman F., and J. Hessling 2006. Assessment of Hormone
Receptor Status in Breast Cancer by Immunohistochemical and Gene Expression Assays.
AACR Cancer Biomarker Conference.
December 2009
15
Anderson SM, Belzer SW, Loeffelholz MJ, Lembke BD and MJ Bankowski. 2006 Validation
of a Real-Time PCR Method for the Direct Detection of Enterotoxigenic E. coli (ETEC)
in Stool Specimens. Association for Molecular Pathology Annual Meeting.
Sninsky, J, Gillett, C, Lau K, Wang A, Santini C, Sigua C, Iverson A, Vess T, Kim W, Kwok S,
Springhall R, Ryder K, Kam-Morgan L, Eisenberg M. Anderson S, Chang S-Y, Broder
S and A Tutt. 2007 Performance of an RT-PCR multi-gene prognostic signature for
distant metastasis from N-, ER+ breast cancer patients on N-, ER+ Tamoxifen-treated
patients using FFPE sections. Miami Breast Cancer Symposium
Iverson A., Santini C., Vess T., Kam-Morgan L., Wang A., Eisenberg M., Anderson S.,
Sninsky J., Chang S., and J. Hessling. 2007. Multiplex TaqMan assay for quantitative
detection of hormone receptors in breast cancer fixed sections. American Association of
Clinical Chemistry Annual Meeting.
Nye M.B., Amos R.N., Christensen E., Anderson S., and B.A. Body. 2008 Performance of a
Laboratory Developed Test Using Invader HPV ASR and GPR components on 1000
Consecutive ThinPrep Specimens with Hybrid Capture 2 and Cytology Results.
Clearwater Virology Annual Symposium
Nye M.B., Amos R.N., Christensen E., Anderson S., and B.A. Body. 2008 Evauation of
Invader HPV ASR as an Alternative for ThinPrep Specimens Quantity Not Sufficient for
Hybrid Capture 2 Testing. Clearwater Virology Annual Symposium
Wang A., Rowland C. , Chew K., Chang S.-Y., Broder S., Bennington J., Gray J., Anderson S.,
Sninsky J., and F. Waldman. 2008. Comparing prognostic value of Ki-67 labeling index
with a 14-gene expression signature in early-stage breast cancer. AACR EORTC
Meeting.
Anderson S., Kam-Morgan L., Chatterjee A. and M. Eisenberg. 2008. Gene Methylation
Markers in Prostate Cancer. ASCO-NCI-EORTC Molecular Markers in Cancer Meeting
Sninsky J., Wang A., Rowland C., Chow K., Anderson S., Gray J., Broder S., Bennington J., and
F. Waldman. 2008. Comparing Prognostic Value of Ki-67 Labeling Index with 14 Gene
Expression Signature in Early Stage Breast Cancers. ASCO-NCI-EORTC Molecular
Markers in Cancer Meeting.
Iwata H, Wang A, Gillett C, Higashimoto H, Lagier R, Rowland C, Anderson S, Broder S,
Sninsky J, and A. Tutt. 2009 A 14-gene prognosis signature predicts metastasis risk in
node-negative, estrogen receptor-positive, Tamoxifen-treated breast cancer in different
ethnogeographic regions. Miami Breast Cancer Symposium
Iwata H, Wang A, Gillett C, Higashimoto H, R. Lagier2, Rowland C, Anderson S, Broder S,
Sninsky J, and A. Tutt 2009. Risk stratification of distant metastasis by progesterone
receptor and a 14-gene expression signature for prognostic value in tamoxifen-treated
breast cancer. San Francisco Breast Cancer Symposium.
December 2009
16
Anderson S, Kam-Morgan L, Kallam E, Cai L, and M Eisenberg. 2009. Promoter Methylation
of the MGMT Gene Determined by Quantitative Methylation Specific PCR. ASCOEORTC-NCI Annual Meeting.
Cai L,Kam-Morgan L, Eisenberg M, and S Anderson. 2009. Detection of K-RAS Oncogene
Mutations Using PCR and Pyrosequencing Methods. ASCO-EORTC-NCI Annual
Meeting.
Papenhausen P, Schwartz S, Tepperberg J, and S. Anderson. 2009. Homozygotic Blocks Reveal
LD Associated with UPD in SNP Arrays. Association of Molecular Pathology Annual
Meeting.
Weck K, Irvin W, Friedman K, Anderson S, Olajide O, Dees E, Peppercorn J, Chiu M., Walko
C, Evans J, McCleod H, and L. Carey. 2009. Use of the Roche Amplichip for CYP2D6
Genotyping to Determine Tamoxifen Dose in a Multiracial Breast Cancer Population.
Association of Molecular Pathology Annual Meeting.
Anderson S, Kam-Morgan L, Kallam E, Chatterjee A, and M. Eisenberg. 2009. Promoter
Methylation of GST-P1 and APC in Prostate Cancer. Association of Molecular
Pathology Annual Meeting.
Kam-Morgan L, Kallam E, Cai L, Eisenberg M and S. Anderson. 2009. Promoter Methylation
of the MGMT Gene Determined by Quantitative Methylation Specific PCR. Association
of Molecular Pathology Annual Meeting.
Irvin W, Walko C, Dees E, Chiu W, Lange L, Olajide O, Raab R, Corso S, Evans J, Weck K,
Peppercorn J, Anderson S, Friedman K, Ogburn E, Desta Z, Flockhart D, McLeod H and
L. Carey. 2009. San Antonio Breast Cancer Meeting.
December 2009
17